Fulcrum Therapeutics, Inc. (NASDAQ:FULC) is one of the 12 best multibagger stocks to buy heading into 2026. Following ...
J.P. Morgan, Leerink Partners, and Cantor are acting as book-running managers for the offering. Oppenheimer & Co. and Truist Securities are also acting as book-running managers for the offering. The ...
The Takeaway: The Sharq is a high-quality, great-performing wheelset for fat tire road bikes with user-friendly features. It ...
Fulcrum Therapeutics, Inc.® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare ...
Fulcrum Therapeutics (NASDAQ:FULC) fell ~10% on Tuesday after the company posted data from a late-stage study of its lead candidate, Pociredir, in sickle cell disease, along with second quarter ...
Ten months after saying its losmapimod treatment had performed no better than placebo in an interim analysis, Fulcrum Therapeutics once again has said the oral drug failed to meet the primary endpoint ...
Fulcrum Therapeutics, Inc.'s pociredir shows promise in treating Sickle Cell Disease, with key data from 12 mg and 20 mg cohorts expected in mid and late 2025 respectively. Despite a setback with ...
New roadmap introduces intelligent, hands-free operations powered by Agentic AI, setting a bold new standard for productivity, safety, and compliance in critical infrastructure industries San ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
'We see this warranty as a good way to give customers a financial backstop on the cybersecurity investments they make with Fulcrum IT Partners,’ says Fulcrum IT Partners US and Canada President Kyle ...
ATLANTA--(BUSINESS WIRE)--Fulcrum Equity Partners, a growth equity firm investing in healthcare services, HCIT, B2B SaaS, and tech-enabled services, announced today it has closed its fourth and ...